You are here

  • Home
  • Archive
  • Volume 20, Issue 5
  • Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Final Analysis of a Phase 2 Double-Blind, Randomized Controlled Trial

Article info

Article menu
Download PDFPDF
Cervical Cancer
Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Final Analysis of a Phase 2 Double-Blind, Randomized Controlled Trial

Authors

  1. Address correspondence and reprint requests to Ryo Konno, MD, PhD, Jichi Medical University, Saitama Medical Center, 1-847, Amanuma, Omiya-ku, Saitama, Saitama, 330-8503, Japan. E-mail: kryo772007{at}yahoo.co.jp.

Citation

Konno R, Tamura S, Dobbelaere K, et al
Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Final Analysis of a Phase 2 Double-Blind, Randomized Controlled Trial
International Journal of Gynecologic Cancer 2010;20:847-855.

Publication history

  • Received January 7, 2010
  • First published June 1, 2010.
Online issue publication 
June 17, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2010 by IGCS and ESGO